Skip to main content

Table 1 Hematologic and blood chemical parameters of main group rats exposed to benzalkonium chloride

From: Assessment of respiratory and systemic toxicity of Benzalkonium chloride following a 14-day inhalation study in rats

 Main group
SexMaleFemale
Concentration (mg/m3)00.842000.8420
Hematology
 WBC (× 103/μL)4.17 ± 0.734.56 ± 0.463.47 ± 0.723.07 ± 0.844.42 ± 0.594.09 ± 0.543.55 ± 0.602.50 ± 0.39b
 RBC (×106/μL)8.40 ± 0.298.68 ± 0.168.97 ± 0.13b9.56 ± 0.19b9.04 ± 0.218.82 ± 0.109.21 ± 0.159.54 ± 0.37
 HCT (%)43.52 ± 1.2744.56 ± 1.1745.42 ± 0.69a48.12 ± 1.16b45.28 ± 0.5944.48 ± 0.6146.12 ± 0.7647.58 ± 2.35
 Hb (g/dL)14.50 ± 0.2614.96 ± 0.21a15.42 ± 0.30b16.44 ± 0.34b15.60 ± 0.2415.32 ± 0.4215.86 ± 0.2316.40 ± 0.67
 MCV (fL)51.84 ± 1.0651.30 ± 0.5750.62 ± 0.5950.32 ± 0.37c50.14 ± 0.6750.40 ± 0.4650.06 ± 0.3949.88 ± 0.51
 MCH (g/dL)17.28 ± 0.3717.24 ± 0.1517.20 ± 0.3717.22 ± 0.1617.28 ± 0.2817.38 ± 0.3517.20 ± 0.1017.20 ± 0.07
 MCHC (g/dL)33.28 ± 0.5233.62 ± 0.5033.96 ± 0.4934.16 ± 0.37a34.46 ± 0.2534.44 ± 0.7234.36 ± 0.1734.46 ± 0.39
 RETA (× 109/L)260.70 ± 41.33241.48 ± 22.83190.72 ± 17.5230.48 ± 2.94d186.50 ± 40.82162.16 ± 28.66139.66 ± 14.54137.66 ± 15.18
 RET (%)3.12 ± 0.582.79 ± 0.292.12 ± 0.200.32 ± 0.03d2.07 ± 0.501.84 ± 0.331.52 ± 0.181.44 ± 0.12c
 PLT (×103/μL)928 ± 39892 ± 23823 ± 43b510 ± 39b840 ± 49806 ± 47844 ± 78842 ± 73
 LYMA (×103/μL)3.22 ± 0.513.58 ± 0.412.45 ± 0.582.23 ± 0.67a3.35 ± 0.513.22 ± 0.582.68 ± 0.641.78 ± 0.19b
 MONA (×103/μL)0.08 ± 0.020.10 ± 0.010.07 ± 0.030.07 ± 0.040.13 ± 0.030.09 ± 0.010.09 ± 0.040.07 ± 0.02b
 EOSA (×103/μL)0.05 ± 0.010.07 ± 0.020.08 ± 0.02a0.05 ± 0.020.06 ± 0.010.07 ± 0.030.07 ± 0.020.06 ± 0.01
 EOS% (%)1.20 ± 0.271.46 ± 0.262.34 ± 0.23a1.80 ± 0.901.40 ± 0.251.78 ± 0.902.02 ± 0.312.38 ± 0.30
 BAS%(%)0.32 ± 0.050.26 ± 0.090.18 ± 0.08a0.18 ± 0.08a0.30 ± 0.140.32 ± 0.050.22 ± 0.080.26 ± 0.18
 APTT (sec)16.26 ± 0.6717.10 ± 0.5518.12 ± 0.6621.08 ± 1.89d17.44 ± 1.4616.88 ± 0.5117.78 ± 0.7019.32 ± 0.92a
 PT (sec)11.00 ± 0.3810.98 ± 0.6112.04 ± 0.42a12.78 ± 0.68b11.18 ± 0.3711.58 ± 0.3012.64 ± 0.54b13.70 ± 0.41b
Clinical chemistry
 ALT (IU/L)36.06 ± 3.0437.28 ± 3.5235.24 ± 2.6447.22 ± 11.48a30.14 ± 2.5928.02 ± 3.3932.34 ± 3.2436.52 ± 5.64
 ALP (IU/L)914.28 ± 71.49896.70 ± 51.47788.74 ± 45.07a675.46 ± 74.70b599.54 ± 44.44592.44 ± 52.97647.14 ± 21.79639.04 ± 74.65
 TG (mg/dL)53.98 ± 20.0949.26 ± 9.0627.02 ± 6.1217.92 ± 1.44b16.76 ± 3.5216.26 ± 5.6212.88 ± 2.3916.56 ± 2.96
 CK (U/L)618.66 ± 142.76583.08 ± 163.15545.66 ± 130.72244.94 ± 41.77b242.06 ± 35.26297.80 ± 148.68257.30 ± 106.39212.24 ± 63.77
 Cl (mmol/L)94.62 ± 0.7196.32 ± 3.0595.56 ± 0.2091.06 ± 2.8897.62 ± 1.4097.78 ± 0.6199.04 ± 0.6397.32 ± 1.15
 K (mmol/L)4.52 ± 0.224.62 ± 0.134.80 ± 0.194.64 ± 0.374.08 ± 0.164.06 ± 0.114.32 ± 0.15a4.26 ± 0.13
 Na (mmol/L)134.70 ± 0.49135.72 ± 2.96134.98 ± 0.67136.34 ± 1.176134.58 ± 0.52135.22 ± 0.61136.80 ± 0.83b138.10 ± 0.77b
  1. The values are expressed as mean ± SD (n = 5 males and 5 females per group)
  2. aDunnett Test Significant at the 0.05 level, bDunnett Test Significant at the 0.01 level
  3. cDunn Rank Sum Test Significant at the 0.05 level, dDunn Rank Sum Test Significant at the 0.01 level